The FDA rule on LDT regulation will limit patient access to essential tests and stifle innovation needed to deliver equitable, effective care for all.


Lab results can disagree depending on where tests are performed. ADLM is working toward harmonizing—or ensuring uniformity—among tests so that patients receive the same diagnosis no matter where they live.

News and Resources
Keep up with fast-moving news and policy actions affecting clinical laboratories and use our tools to act on grassroots campaigns.
-
Position Statements
ADLM identifies priority issues for members and communicates the association's positions to policymakers through research-based position statements.
-
Comment Letters
Explore official statements sent to Congress and federal regulatory authorities.
-
Laboratory Voice
Learn how to take quick action to contact your representatives on key issues in laboratory medicine.


